Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2001 3
2003 3
2004 2
2005 2
2006 2
2007 5
2009 3
2010 2
2011 5
2012 3
2013 2
2014 1
2015 2
2016 3
2017 1
2018 5
2019 6
2020 1
2021 6
2022 7
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Thai clinicians' attitudes toward antimicrobial stewardship programs.
Sutthiruk N, Considine J, Hutchinson A, Driscoll A, Malathum K, Botti M. Sutthiruk N, et al. Among authors: malathum k. Am J Infect Control. 2018 Apr;46(4):425-430. doi: 10.1016/j.ajic.2017.09.022. Epub 2017 Nov 10. Am J Infect Control. 2018. PMID: 29132695
Thailand's national strategic plan on antimicrobial resistance: progress and challenges.
Sumpradit N, Wongkongkathep S, Malathum K, Janejai N, Paveenkittiporn W, Yingyong T, Chuxnum T, Vijitleela A, Boonyarit P, Akaleephan C, Manosuthi W, Thienthong V, Srinha J, Wongsrichai S, Laoprasert T, Athipunyakom P, Kriengchaiyaprug N, Intarukdach K, Numsawad S, Somjetanakul N, Punnin S, Kiatying-Angsulee N. Sumpradit N, et al. Among authors: malathum k. Bull World Health Organ. 2021 Sep 1;99(9):661-673. doi: 10.2471/BLT.20.280644. Epub 2021 Jul 1. Bull World Health Organ. 2021. PMID: 34475603 Free PMC article.
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).
Boongird S, Setthaudom C, Kitpermkiat R, Prasongtanakij S, Srisala S, Chuengsaman P, Nongnuch A, Assanatham M, Kiertiburanakul S, Malathum K, Phuphuakrat A, Bruminhent J. Boongird S, et al. Among authors: malathum k. Vaccines (Basel). 2022 Jul 1;10(7):1064. doi: 10.3390/vaccines10071064. Vaccines (Basel). 2022. PMID: 35891228 Free PMC article.
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J, Setthaudom C, Kitpermkiat R, Kiertiburanakul S, Malathum K, Assanatham M, Nongnuch A, Phuphuakrat A, Chaumdee P, Janphram C, Thotsiri S, Chuengsaman P, Boongird S. Bruminhent J, et al. Among authors: malathum k. Sci Rep. 2022 Mar 4;12(1):3587. doi: 10.1038/s41598-022-07574-w. Sci Rep. 2022. PMID: 35246578 Free PMC article.
Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
Phuphuakrat A, Pasomsub E, Srichatrapimuk S, Kirdlarp S, Suksatu A, Srisaowakarn C, Manopwisedjaroen S, Ludowyke N, Purwono PB, Priengprom T, Wongsa A, Thakkinstian A, Hongeng S, Malathum K, Thitithanyanont A, Tassaneetrithep B. Phuphuakrat A, et al. Among authors: malathum k. Microbiol Spectr. 2022 Jun 29;10(3):e0050322. doi: 10.1128/spectrum.00503-22. Epub 2022 May 23. Microbiol Spectr. 2022. PMID: 35604133 Free PMC article.
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Setthaudom C, Bruminhent J. Boongird S, et al. Among authors: malathum k. Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34419552 Free PMC article. No abstract available.
An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study).
Bruminhent J, Setthaudom C, Phornkittikorn P, Chaumdee P, Prasongtanakij S, Srisala S, Malathum K, Boongird S, Nongnuch A, Assanatham M, Nakgul L, Sanmeema N, Phuphuakrat A, Kiertiburanakul S; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Bruminhent J, et al. Among authors: malathum k. Am J Transplant. 2022 Nov;22(11):2651-2660. doi: 10.1111/ajt.17151. Epub 2022 Jul 26. Am J Transplant. 2022. PMID: 35841235 Free PMC article. Clinical Trial.
Impact of Carbapenem Peri-Transplant Prophylaxis and Risk of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Early Urinary Tract Infection in Kidney Transplant Recipients: A Propensity Score-Matched Analysis.
Aramwittayanukul S, Malathum K, Kantachuvesiri S, Arpornsujaritkun N, Chootip P, Bruminhent J. Aramwittayanukul S, et al. Among authors: malathum k. Front Med (Lausanne). 2022 Jun 6;9:841293. doi: 10.3389/fmed.2022.841293. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35733866 Free PMC article.
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).
Bruminhent J, Setthaudom C, Chaumdee P, Boongird S, Kiertiburanakul S, Malathum K, Nongnuch A, Phuphuakrat A, Jirasiritham S, Janphram C, Thotsiri S, Upama S, Assanatham M; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Bruminhent J, et al. Among authors: malathum k. Am J Transplant. 2022 Mar;22(3):813-822. doi: 10.1111/ajt.16867. Epub 2021 Dec 6. Am J Transplant. 2022. PMID: 34657386 Free PMC article.
60 results